JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 2, 2004; DOI: 10.1124/jpet.103.062224


0022-3565/04/3101-59-66$20.00
JPET 310:59-66, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.062224v1
jpet.103.062224v2
310/1/59    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Van de Kar, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Van de Kar, L. D.

NEUROPHARMACOLOGY

Desensitization of 5-HT1A Receptors by 5-HT2A Receptors in Neuroendocrine Neurons in Vivo

Yahong Zhang, Thackery S. Gray, Deborah N. D'Souza, Gonzalo A. Carrasco, Katerina J. Damjanoska, Bertalan Dudas, Francisca Garcia, Gina M. Zainelli, Nicole R. Sullivan Hanley, George Battaglia, Nancy A. Muma, and Louis D. Van de Kar

Center for Serotonin Disorders Research and Department of Pharmacology (Y.Z., T.S.G., D.N.D., G.A.C., K.J.D., B.D., F.G., G.M.Z., N.R.S.H., G.B., N.A.M., L.D.V.d.K.) and Department of Cell Biology, Neurology, and Anatomy (T.S.G.), Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois

An imbalance between serotonin-2A (5-HT2A) and 5-HT1A receptors may underlie several mood disorders. The present studies determined whether 5-HT2A receptors interact with 5-HT1A receptors in the rat hypothalamic paraventricular nucleus (PVN). The sensitivity of the hypothalamic 5-HT1A receptors was measured as oxytocin and adrenocorticotropic hormone (ACTH) responses to the 5-HT1A receptor agonist (+)-8-hydroxy-2-(di-n-propylamino) tetralin hydrobromide [(+)8-OH-DPAT] (40 µg/kg s.c.). The 5-HT2A/2C receptor agonist (-)DOI [(-)-1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane HCl] (1 mg/kg s.c.) injected 2 h prior to (+)8-OH-DPAT significantly reduced the oxytocin and ACTH responses to (+)8-OH-DPAT, producing a heterologous desensitization of the 5-HT1A receptors. Microinjection of the 5-HT2A receptor antagonist MDL100,907 [(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinemethanol; 0, 10, or 20 nmol, 15 min prior to (-)DOI] into the PVN dose-dependently prevented the desensitization of 5-HT1A receptors induced by the 5-HT2A receptor agonist (-)DOI. Double-label immunocytochemistry revealed a high degree of colocalization of 5-HT1A and 5-HT2A receptors in the oxytocin and corticotropin-releasing factor neurons of the PVN. Thus, activation of 5-HT2A receptors in the PVN may directly induce a heterologous desensitization of 5-HT1A receptors within individual neuroendocrine cells. These findings may provide insight into the long-term adaptation of 5-HT1A receptor signaling after changes in function of 5-HT2A receptors; for example, during pharmacotherapy of mood disorders.


Received January 8, 2004; accepted April 2, 2004.

Address correspondence to: Dr. Louis D. Van de Kar, Department of Pharmacology, Loyola University of Chicago, Stritch School of Medicine, 2160 South First Avenue, Maywood, Illinois 60153. E-mail: lvandek{at}lumc.edu




This article has been cited by other articles:


Home page
J. Neurosci.Home page
L. K. Heisler, N. Pronchuk, K. Nonogaki, L. Zhou, J. Raber, L. Tung, G. S. H. Yeo, S. O'Rahilly, W. F. Colmers, J. K. Elmquist, et al.
Serotonin Activates the Hypothalamic-Pituitary-Adrenal Axis via Serotonin 2C Receptor Stimulation
J. Neurosci., June 27, 2007; 27(26): 6956 - 6964.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. A. Carrasco, L. D. Van de Kar, C. Jia, H. Xu, Z. Chen, R. Chadda, F. Garcia, N. A. Muma, and G. Battaglia
Single Exposure to a Serotonin 1A Receptor Agonist, (+)8-Hydroxy-2-(di-n-propylamino)-tetralin, Produces a Prolonged Heterologous Desensitization of Serotonin 2A Receptors in Neuroendocrine Neurons in Vivo
J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1078 - 1086.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Osei-Owusu, A. James, J. Crane, and K. E. Scrogin
5-Hydroxytryptamine 1A Receptors in the Paraventricular Nucleus of the Hypothalamus Mediate Oxytocin and Adrenocorticotropin Hormone Release and Some Behavioral Components of the Serotonin Syndrome
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1324 - 1330.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Q. Li, A. Holmes, L. Ma, L. D. Van de Kar, F. Garcia, and D. L. Murphy
Medial Hypothalamic 5-Hydroxytryptamine (5-HT)1A Receptors Regulate Neuroendocrine Responses to Stress and Exploratory Locomotor Activity: Application of Recombinant Adenovirus Containing 5-HT1A Sequences
J. Neurosci., December 1, 2004; 24(48): 10868 - 10877.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.